Red Mulberry Allergy Shots: Native Eastern Moraceae and Food OAS
Red mulberry (Morus rubra) is North America's native Moraceae species — distinct from the Asian white mulberry planted as a desert Southwest urban ornamental. With monoecious or mixed-sex populations and lower airborne pollen loads than fruitless white mulberry male clones, red mulberry is a spring allergen in Eastern hardwood forests and the Southeast.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Red Mulberryis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Red Mulberry Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to red mulberry — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of red mulberry allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of red mulberry immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of red mulberry extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for red mulberry allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing red mulberry extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription red mulberry immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat red mulberry allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Red Mulberry?
The biology, taxonomy, and clinical fingerprint of Red Mulberry — the foundation of how SCIT targets it.
Red mulberry is North America's native Moraceae species, found in Eastern bottomland and mixed hardwood forests; unlike white mulberry's male-only urban clones, natural pollen loads are far lower.
- Scientific name
- Morus rubra
- Family
- MoraceaeMulberry family
- Type
- Tree pollen — wind-pollinated; monoecious or imperfectly dioecious native hardwood
- Native to
- Eastern US east of Texas; bottomland and mixed hardwood forests
- Allergen proteins
- Mor a 2 — cobalamin-independent methionine synthase (cross-reactive from M. alba characterization)Mor n 3 — non-specific lipid transfer protein (nsLTP); fruit and pollen cross-reactive
- Particle size
- ~17 µm, wind-pollinated
- Avoidance difficulty
- Moderate
How Red Mulberry Allergy Presents
Symptoms by body system — useful for distinguishing Red Mulberry sensitivity from overlapping allergies and infections.
Respiratory
- Sneezing and rhinorrhea during the March–May red mulberry pollen season in Eastern US
- Nasal congestion coinciding with spring mulberry flowering in bottomland forests
- Post-nasal drip on high-count spring days near mulberry-rich woodland edges
- Seasonal asthma exacerbation in sensitive patients near dense Morus rubra stands
- Cough from inhaled mulberry pollen during windy spring conditions
Ocular
- Watery, itchy eyes during March–May Eastern mulberry pollen season
- Conjunctival redness and periorbital swelling during peak exposure near woodland habitats
- Contact lens intolerance during spring mulberry pollen season
- Eye symptoms accompanying rhinitis in mulberry-sensitized patients
Dermal
- Atopic dermatitis flares during the spring Morus rubra pollen window
- Contact urticaria after handling mulberry fruit in Mor n 3-sensitized patients
- Oral mucosal tingling when eating fresh fig, peach, or mulberry fruit (LTP-mediated)
Systemic
- Fatigue and reduced concentration during peak spring Eastern mulberry exposure
- Sleep disruption from nasal congestion during the March–May pollen window
- Generalized malaise in patients co-sensitized to red mulberry, oak, and spring grasses
- Headache from sustained sinus pressure during spring pollen peaks
Red mulberry doesn't make headlines like the Phoenix white mulberry plantings — but in the Mississippi bottomlands and Appalachian foothills, it's the spring tree my patients can identify by the stained sidewalks under their windows and the mulberries that appear in May.
When & Where Red Mulberry Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: April in the Eastern US — overlapping the spring oak and early grass pollen season· ~8–10 weeks of pollen season across Eastern hardwood forests and the Southeast
US Exposure Map
7 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Low
- MT:
- Low
- ND:
- Low
- MN:
- Low
- WI:
- Low
- MI:
- Low
- NY:
- Low
- MA:
- Low
- OR:
- Low
- ID:
- Low
- WY:
- Low
- SD:
- Low
- IA:
- Low
- IL:
- Moderate
- IN:
- Moderate
- OH:
- Moderate
- PA:
- Moderate
- NJ:
- Moderate
- CT:
- Low
- RI:
- Low
- CA:
- Low
- NV:
- Low
- UT:
- Low
- CO:
- Low
- NE:
- Low
- MO:
- Moderate
- KY:
- High
- WV:
- Moderate
- VA:
- Moderate
- MD:
- Moderate
- DE:
- Moderate
- AZ:
- Low
- NM:
- Low
- KS:
- Low
- AR:
- High
- TN:
- High
- NC:
- Moderate
- SC:
- Moderate
- OK:
- Moderate
- LA:
- High
- MS:
- High
- AL:
- High
- GA:
- High
- TX:
- Low
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Red Mulberry Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Red mulberry cross-reactivity is driven by Mor n 3 (nsLTP), which links mulberry pollen to food OAS with fig, peach, and mulberry fruit; intra-Morus cross-reactivity with white mulberry is strong.
Direct intra-species LTP-mediated cross-reactivity
Moraceae family LTP cross-reactivity; fig OAS in Mor n 3-sensitized patients
LTP-mediated OAS; Pru p 3 and Mor n 3 cross-reactivity
Mulberry-Fig-Peach Syndrome
Mor n 3 (nsLTP) in red mulberry pollen cross-reacts with fig, peach, and mulberry fruit; reactions are heat-stable (unlike Bet v 1-based OAS) and can persist with cooked food forms.
Is SCIT Right for Your Red Mulberry Allergy?
Answer five questions to assess whether red mulberry SCIT fits your Eastern spring rhinitis profile.
How severe are your March–May spring allergy symptoms in the Eastern US or Southeast?
The Red Mulberry SCIT Protocol
Red mulberry SCIT uses a non-standardized Morus extract, typically the same formulation as white mulberry given the strong intra-Morus cross-reactivity via Mor a 2 and Mor n 3.
Starting from the most dilute mulberry extract, your allergist escalates to the maintenance dose over 6–8 months. Build-up is ideally timed to complete before the March mulberry pollen onset. The 30-minute post-injection observation period is mandatory at every visit.
Ongoing maintenance injections continue through successive spring seasons. Annual symptom diaries help track improvement across the April peak. The 30-minute observation period is required at each maintenance visit.
After completing the recommended course, durable post-treatment benefit is the goal, consistent with broader non-standardized tree SCIT data.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Red Mulberry SCIT
No SCIT RCT has been published specifically for red mulberry. Evidence is extrapolated from white mulberry allergen characterization and the broader non-standardized tree SCIT evidence base.
- Intra-Morus cross-reactivity (M. rubra / M. alba shared proteins)85%WHO/IUIS Allergen Nomenclature database; Mor a 2 and Mor n 3 cross-species reactivity characterization
- Estimated benefit from non-standardized tree SCIT (extrapolated)48%Cox L et al., J Allergy Clin Immunol 2011;127:S1–S55 — Practice Parameter Third Update
Red mulberry SCIT lacks dedicated RCT evidence. The strong intra-Morus cross-reactivity via Mor a 2 and Mor n 3 means that white mulberry extract studies and characterization data are directly applicable to red mulberry sensitization. Clinical prescribing follows the AAAAI/ACAAI Practice Parameter for confirmed sensitization with inadequate pharmacotherapy response.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Red Mulberry SCIT Side Effects
Red mulberry SCIT side effects are consistent with non-standardized inhalant tree extracts; local reactions are most common and serious systemic events are rare.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site erythema and swelling Most common; resolves within a few hours | Rate 25–50% | Mild |
Injection-site pruritus Cool compress provides relief | Rate 20–35% | Mild |
Large local reaction Swelling >5 cm; may require dose adjustment | Rate 5–10% | Moderate |
Delayed local soreness Induration 4–8 hours post-injection; self-limited | Rate 5–8% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis or conjunctivitis flare Transient; resolves spontaneously | Rate 0.5–1% | Mild |
Urticaria Hives beyond injection site; requires clinical evaluation | Rate 0.1–0.3% | Moderate |
Mild bronchospasm Pre-injection asthma assessment important; bronchospasm is managed promptly, and Curex confirms a prescribed epinephrine auto-injector is on hand with the first injection from each new vial or concentration supervised live in the Virtual Shot Room. | Rate 0.1–0.2% | Moderate |
Anaphylaxis Extremely rare; a 30-minute self-observation, a prescribed epinephrine auto-injector confirmed on hand, and live Zoom supervision of the first injection from each new vial or concentration is designed to detect it immediately. | Rate <0.01% | Severe |
SCIT has traditionally been administered in a clinic equipped for emergency treatment; for eligible patients, Curex makes safe at-home self-administration possible with a personalized serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first injection from each new vial or concentration supervised live in the Virtual Shot Room. A 30-minute observation follows every dose and remains a core safety step.
SCIT vs Alternatives for Red Mulberry
Eastern spring mulberry allergy management ranges from targeted pharmacotherapy through sublingual immunotherapy to SCIT — now available as a weekly at-home shot with Curex; the right choice depends on symptom severity and proximity to dense red mulberry populations.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Moderate (no RCT) | Comparable (extrapolated) | Partial — native woodland | Good short-term control |
| 5-yr cost | $3,500–$9,000 | Varies by provider | Low | $500–$2,000/yr |
| Duration | 3–5 years | 3–5 years | Ongoing | Lifelong |
| Convenience | Weekly at-home build-up easing to ongoing maintenance with Curex | Daily drops at home | Difficult near forests | Daily pill/spray |
| Safety | Very safe; sterile-compounded serum plus live Zoom supervision of every dose change | Very safe | Excellent | Generally safe |
| Lasting effect | Yes, years post-tx | Yes, years post-tx | No | No |
SCITBest
SLIT
Avoidance
Medications
For confirmed red mulberry sensitization with multi-season Eastern spring symptoms, SCIT offers the most durable long-term benefit — and with Curex, eligible patients self-administer that shot at home with pricing confirmed in a current program quote instead of managing weekly clinic visits, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room and a prescribed epinephrine auto-injector confirmed on hand.
What Red Mulberry SCIT Actually Costs
Most major US insurers cover red mulberry SCIT under standard allergy benefits when prescribed by a board-certified allergist with documented positive Morus sensitization; prior authorization is typically supported by a spring allergic rhinitis diagnosis. Curex at-home IgE testing identifies specific red mulberry sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your red mulberry allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Red Mulberry SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Red mulberry (Morus rubra) is North America's native Moraceae species, found in Eastern bottomland and mixed hardwood forests east of Texas. White mulberry (Morus alba) is an Asian species widely planted in desert Southwest cities as a fruitless male ornamental. Both share strong intra-Morus cross-reactivity via Mor a 2 and Mor n 3, meaning sensitization to one likely means reactivity to the other. The practical clinical difference is exposure intensity — red mulberry produces natural pollen loads in forest settings, while white mulberry male-clone urban plantings produce extreme pollen loads in cities like Phoenix and Tucson. Red mulberry's monoecious or mixed-sex populations have lower average airborne pollen concentrations than the all-male fruitless Southwest urban clones.
Yes — this is possible if you are sensitized to Mor n 3 (non-specific lipid transfer protein, nsLTP), which is present in both red mulberry pollen and mulberry fruit. Unlike the birch-food syndrome where cooking typically eliminates reactivity because Bet v 1 is heat-labile, nsLTP-mediated reactions can persist with cooked or processed mulberry products because nsLTP proteins are heat-stable. Reactions can include oral tingling, lip swelling, urticaria, or in rare cases more systemic symptoms. Cross-reactivity via Mor n 3 also extends to fig and peach. If you notice symptoms after eating fresh mulberries, fig, or peach, discuss this with a board-certified allergist — specific IgE testing to Mor n 3 can confirm whether LTP sensitization is present.
Red mulberry is a real Eastern and Southeastern US spring allergen, though far less dominant than white mulberry is in the desert Southwest. It is most clinically relevant in the Mississippi bottomlands, Appalachian foothills, Gulf states, and eastern woodland areas where it grows as a native understory tree. No large-scale US sensitization prevalence study specific to Morus rubra has been published, but the strong intra-Morus cross-reactivity with the better-studied white mulberry means that positive IgE to mulberry in Eastern patients likely reflects M. rubra exposure in their local woodland environment. Patients near dense mulberry stands — identifiable by the characteristic purple-stained sidewalks under the trees in May — have the highest relevant exposure.
Red mulberry SCIT follows the standard non-standardized tree extract protocol: a build-up phase of approximately 6–8 months of weekly injections, followed by a maintenance phase of maintenance injections for 3–5 years. Most patients notice meaningful improvement after one or two full spring mulberry seasons on the maintenance dose — typically 12–24 months into treatment. Because no red-mulberry-specific or white-mulberry-specific SCIT RCT has been published, these timelines extrapolate from the broader non-standardized tree SCIT literature and the AAAAI/ACAAI Practice Parameter (Cox 2011). Consistent adherence to the injection schedule is the primary determinant of treatment success.
Allergen immunotherapy for red mulberry pollen targets the pollen allergen proteins (Mor a 2, Mor n 3) and primarily reduces respiratory and ocular pollen symptoms. Whether mulberry SCIT also reduces nsLTP-mediated food reactivity to fig and peach is not well-studied — there is no published controlled trial of mulberry SCIT for pollen-food syndrome. For birch-related pollen-food syndrome (Bet v 1-mediated), birch SCIT has demonstrated modest reduction in food OAS in some studies. An analogous benefit from mulberry SCIT on Mor n 3-mediated food reactivity is plausible but unproven. Inform your allergist of any food reactions so they can assess whether oral food challenge or additional management is appropriate alongside your pollen immunotherapy.
Most major US health insurers cover red mulberry SCIT under standard allergy benefits when prescribed by a board-certified allergist with documented positive Morus sensitization. In Eastern and Southeastern states where red mulberry is a recognized spring woodland allergen, a spring allergic rhinitis diagnosis typically supports coverage approval. Prior authorization is commonly required; your allergist's billing office can assist. Out-of-pocket costs over a 5-year SCIT course typically range from $3,500 to $9,000 depending on plan deductible and co-insurance.
Yes — red mulberry SCIT is appropriate for pediatric patients with confirmed Morus sensitization and spring symptoms not adequately controlled by antihistamines and nasal steroids. The AAAAI/ACAAI Practice Parameters support allergen immunotherapy in children typically from age 5 onward, with build-up doses adjusted for body weight and skin-test reactivity. The mandatory 30-minute post-injection observation period is equally important in children, and parents should be instructed in recognizing early signs of a systemic reaction. Reassuringly, a large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) found a systemic reaction rate of just 0.16% per patient across 23,614 patients giving 2,021,600 injections, with no fatalities — lower than the 3%–14% typically seen with office-based shots. Note: Curex's at-home pilot is currently open to patients age 12 and older; pediatric patients require a trained adult caregiver physically present for every injection. A board-certified pediatric allergist can assess whether the child's spring symptom burden and Morus sensitization pattern support proceeding with immunotherapy.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.